Patents by Inventor Kyosuke Masaki

Kyosuke Masaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isoflavone-containing composition
    Patent number: 7939060
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been available.
    Type: Grant
    Filed: January 9, 2008
    Date of Patent: May 10, 2011
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
  • ISOFLAVONE-CONTAINING COMPOSITION
    Publication number: 20080131412
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been available.
    Type: Application
    Filed: January 9, 2008
    Publication date: June 5, 2008
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
  • Microbial method of making equol-containing composition and product made
    Patent number: 7345089
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been available.
    Type: Grant
    Filed: January 8, 2004
    Date of Patent: March 18, 2008
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
  • Isoflavone-containing composition
    Publication number: 20040141954
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly women for which no effective means of prevention or alleviation has heretofore been avai lable.
    Type: Application
    Filed: January 8, 2004
    Publication date: July 22, 2004
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
  • Streptococcus and isoflavone-containing composition
    Patent number: 6716424
    Abstract: This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly woman for which no effective means of prevention or alleviation has heretofore been available.
    Type: Grant
    Filed: February 8, 2000
    Date of Patent: April 6, 2004
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Shigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
  • Liver fat accumulation inhibitory composition, food additive for liver fat accumulation, inhibition, and method of inhibiting liver fat accumulation
    Patent number: 6468556
    Abstract: A method of inhibiting liver fat accumulation which comprises administering a conjugated linoleic acid homolog to a mammal or making the mammal ingest it; and a liver fat accumulation inhibitory composition characterized by containing an effective amount of a conjugated linoleic acid homolog together with a support for medicinal preparations or foods. The administration or ingestion of CLA inhibits the total lipid content and the triglyceride content in the liver from increasing, and hence can effectively prevent diseases attributable to fatty liver, such as chronic hepatitis and hepatic cirrhosis.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: October 22, 2002
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Tsuneyuki Noda, Masamichi Toba, Takuma Imada, Kyosuke Masaki, Seiichi Shimizu
  • Pharmaceutical composition for potassium supplementation
    Patent number: 5424074
    Abstract: This invention provides a magnesium-added potassium-supplementing pharmaceutical composition containing 3 to 15 wt. %, as K, of a potassium-containing compound and 0.2 to 5 wt. %, as Mg, of a magnesium-containing compound in a K/Mg weight ratio of 20:1 through 1:1, and particularly a magnesium-added potassium-supplementing pharmaceutical composition in an effervescent dosage form which contains the above-mentioned ingredients, in the indicated ratio, in combination with 7 to 20 percent by weight of a blowing agent and 15 to 60 percent by weight of a neutralizing agent.
    Type: Grant
    Filed: January 31, 1994
    Date of Patent: June 13, 1995
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Hideaki Koli, Hirofumi Ueno, Kyosuke Masaki, Akihisa Takaichi, Toshihiko Okamoto, Toshiaki Matsumoto